Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

Journal of Clinical Oncology

Volumn 26, Issue 35, 2008, Pages 5761-5765

  Matulonis, Ursula A ^a   Horowitz, Neil S ^a   Campos, Susana M ^a   Lee, Hang ^a   Lee, Julie ^a   Krasner, Carolyn N ^a   Berlin, Suzanne ^a   Roche, Maria R ^a   Duska, Linda R ^a   Pereira, Lauren ^a   Kendall, Deborah ^a   Penson, Richard T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PEMETREXED;

ADULT; AGED; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONSTIPATION; DEHYDRATION; DIARRHEA; DIZZINESS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPERSENSITIVITY REACTION; HYPOKALEMIA; HYPOMAGNESEMIA; LEUKOCYTE COUNT; LUNG EMBOLISM; MEMORY DISORDER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVARY CANCER; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; RECURRENT CANCER; SIDE EFFECT; SYNCOPE; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE TUBE CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BOSTON; CARBOPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FALLOPIAN TUBE NEOPLASMS; FEMALE; GLUTAMATES; GUANINE; HUMANS; INFUSIONS, INTRAVENOUS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 57449098425     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.0282     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 57:43-66, 2007
2. Markman M, Rothman R, Hakes T, et al: Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9:389-393, 1991
3. Parmar MK, Ledermann JA, Colombo N, et al: Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/ AGO-OVAR-2.2 trial. Lancet 361:2099-2106, 2003
4. Pfisterer J, Plante M, Vergote I, et al: Gemcitabine/ carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: An intergroup trial of the AGO OVAR, NCIC CTG, and EORTC GCG. J Clin Oncol 24:4699-4707, 2006
5. Shih C, Chen VJ, Gossett LS, et al: LY231514, a pyrrolo(2,3-d)pyrimidine- based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 57:1116-1123, 1997
6. Westerhof GR, Schornagel JH, Kathmann I, et al: Carrier and receptor mediated transport of folate antagonists targeting folate-dependent enzymes: Correlates of molecular structure and biological activity. Mol Pharmacol 48:459-471, 1995
7. Adjei AA: Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent. Clin Cancer Res 10:4276s-4280s, 2004
8. Paz-Ares L, Ciruelos E, Garcia-Carbonero R, et al: Pemetrexed in bladder, head and neck, and cervical cancers. Semin Oncol 29:69-75, 2002 (suppl 18)
9. Wu M, Gunning W, Ratnam M: Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 8:775-782, 1999
10. Garin A, Manikhas A, Biakhov M, et al: A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer. Breast Cancer Res Treat 110:309-315, 2008
11. Hughes A, Calvert P, Azzabi A, et al: Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J Clin Oncol 20:3533-3544, 2002
12. Socinski MA, Weissman C, Hart LL, et al: Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer. J Clin Oncol 24:4840-4847, 2006
13. Zinner RG, Fossella FV, Gladish GW, et al: Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer. Cancer 104:2449-2456, 2005
14. US Food and Drug Administration: Pemetrexed package insert. www.fda.gov/CDER/DRUG/ infopage/alimta/default.htm
15. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
16. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
17. Lee CW, Matulonis UA, Castells MC: Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: Standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 99:393-399, 2005
18. Castells MC, Tennant NM, Sloane DE, et al: Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol [epub ahead of print on May 23, 2008]